# Barclays share price today (Barclays PLC, BCS)

> Barclays PLC's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. BCS · Financials · Banks - Diversified · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/bcs

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from fewer quarters than usual
- Price: $22.40 (+4.2% in a year)
- P/BV: 0.7×, against its own history
- Revenue (Sep 2026): GBP 6.9 B (+4.9% on a year ago)
- Profit (Sep 2026): GBP 1.6 B (+13.0% on a year ago)
- Net margin: 23.8% (+1.7 points on a year ago)
- ROE: 11%, FY25
- ROA: 0.48%, latest

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Barclays share price today? Barclays PLC's share price was $22.40 at the close on 3 November 2026. It has been moving sideways for 8 weeks. That is 9.8% below its average price over the last 200 trading days. In the last 52 weeks it traded between $20 and $28, and at that close it sat 29% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 8 weeks running. Over the last 10 years the share price moved +206% while the S&P 500 moved +255%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 11 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Barclays pay? Barclays PLC declared GBP 0.06 per local share for Jun 2026, and GBP 0.20 over the last four reported quarters. It reports in British pounds, and one US-listed share can stand for several local shares, so we do not set this against the dollar price or show a yield. ## Which stock lists is Barclays on? Barclays is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Barclays profitable? Barclays PLC earned GBP 1.6 B of net profit in the Sep 2026 quarter, +13.0% on the same quarter a year earlier. That is the 4th quarter in a row of profit growth. Full-year FY25 profit was GBP 6.2 B. Over 4 years profit has grown −0.1% a year on average. That is 23.8% of the quarter's revenue. The same quarter a year earlier earned GBP 1.5 B. 1 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was GBP 6.2 B (+16.2% on the year before). Why profit moved: revenue changed +4.9% on a year earlier and the margin moved +1.7 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +19.2% and revenue +9.6%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. This company reports in British pounds, not US dollars, so the money charts are left out here. The figures in the text are in that currency (GBP); nothing is converted. ## How much revenue does Barclays make, and is it growing? Barclays PLC reported GBP 6.9 B of income in the Sep 2026 quarter, +4.9% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 4 years it has grown 4.4% a year on average. The last full year, FY25, came in at GBP 26.8 B. The last four reported quarters add to GBP 28.5 B. FY25 revenue was GBP 26.8 B, +10.6% on the year before. Recent pace: the last four quarters grew +9.6% on average, against 4.4% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +9.4%, against +9.9% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +18.3%, against +28.8% a year (rolling over). This company reports in British pounds, not US dollars, so the money charts are left out here. The figures in the text are in that currency (GBP); nothing is converted. ## How much does Barclays keep from what it earns? Barclays PLC's net margin was 23.8% in the Sep 2026 quarter, 1.7 percentage points higher than the same quarter a year ago. Across 5 years it has been between 18.2% and 27.5%. The latest quarter is within that range. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## How many of Barclays' loans have gone bad? Barclays PLC does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Barclays' loan book growing? Barclays PLC's revenue was GBP 26.8 B in FY25, +10.6% on the year before, so the loan book is growing. The latest quarter was +4.9% on a year earlier. The net margin on that income is 23.8%, +1.7 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch. This company reports in British pounds, not US dollars, so the money charts are left out here. The figures in the text are in that currency (GBP); nothing is converted. ## What is Barclays' P/BV ratio, and how does it compare with its own history? Barclays PLC's P/BV is 0.7×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is low: this lender earns about 11% a year on its equity. A lender that earns less on its net worth is valued lower for each dollar of it, and that gap usually closes only if returns improve. In short: there is too little history to say whether the multiple is high or low for this company, so the book value trend underneath matters more than the multiple. ## Is the Barclays business getting better or worse? Barclays PLC's business is giving mixed signals. There is no clear direction across the growth lines, with ROE steady at 9.1%; each line tells part of the story. This is based on 12 quarters of 3 measures, with some gaps. Why it matters: when the lines disagree, each line above matters more than any single label. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Barclays earn on its equity and assets? Barclays PLC earned a return on equity of 8% in FY25. Its lowest yearly reading on file was 6% in FY23. On its assets, every GBP 100 earned about GBP 0.48, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together. That return is below the level a bank needs to grow its net worth quickly, which helps explain why its multiple is where it is. Why ROE moved: profit grew −0.1% a year over 4 years while net worth grew more slowly. When earnings recover faster than net worth builds up, ROE climbs off its low. ## Does Barclays have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Barclays shareholding pattern? 0.0% of Barclays PLC's tradable shares are in short positions, which are bets that the price will fall, so very few traders are betting against this stock. At normal trading volumes, closing those positions would take about 1.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Barclays from balance-sheet trouble? For Barclays PLC, the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Barclays rank in its industry? 43.8 out of 100, rank 14 of 18 in Banks - Diversified, with 80% of the evidence available. Barclays PLC scores 43.8 out of 100 against the 18 companies it is compared with in Banks - Diversified, ranking 14. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 17.2 + 8 + 17 + 1.6 = 43.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Barclays compared with? Barclays ranks 14 of 18 Banks - Diversified companies on the 4-Factor Sector Score, with 43.8 out of 100. 1. [JPMorgan Chase & Co.](https://www.sectoralpha.in/us/stocks/jpm) JPM · quiet · Most evidence points up · 80% evidence 70.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.2/35 · Income 14.1% · Profit 13.9% · 81% evidence Capital efficiency 20.1/25 · ROA 1.7% · ROE 22.9% · GNPA n/a · 68% evidence Valuation 12.9/20 · P/BV 2.36× · P/BV÷ROE 0.1 · 70% evidence Relative strength 13.5/20 · Lead over its industry 0.3% · Lead over S&P 500 0.2% · 1 year 7.6% · 100% evidence · 5 of 12 weeks ahead Exact sum: 24.2 + 20.1 + 12.9 + 13.5 = 70.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [The Bank of New York Mellon Corporation](https://www.sectoralpha.in/us/stocks/bny) BNY · quiet · Evidence leans up · 80% evidence 64.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/35 · Income 11.5% · Profit 25.6% · 81% evidence Capital efficiency 17.0/25 · ROA 1.3% · ROE 15.8% · GNPA n/a · 68% evidence Valuation 9.8/20 · P/BV 2.22× · P/BV÷ROE 0.14 · 70% evidence Relative strength 16.0/20 · Lead over its industry 6.4% · Lead over S&P 500 6% · 1 year 36.2% · 100% evidence · 5 of 12 weeks ahead Exact sum: 21.9 + 17 + 9.8 + 16 = 64.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Canadian Imperial Bank of Commerce](https://www.sectoralpha.in/us/stocks/cm) CM · turning · Evidence leans up · 80% evidence 63.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Income 15.3% · Profit 23.7% · 81% evidence Capital efficiency 13.8/25 · ROA 0.9% · ROE 15% · GNPA n/a · 68% evidence Valuation 9.0/20 · P/BV 2.25× · P/BV÷ROE 0.15 · 70% evidence Relative strength 16.6/20 · Lead over its industry 5.8% · Lead over S&P 500 5.6% · 1 year 37.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 23.7 + 13.8 + 9 + 16.6 = 63.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [The Bank of Nova Scotia](https://www.sectoralpha.in/us/stocks/bns) BNS · turning · Evidence leans up · 80% evidence 61.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Income 11.6% · Profit 42.3% · 81% evidence Capital efficiency 8.5/25 · ROA 0.7% · ROE 11.9% · GNPA n/a · 68% evidence Valuation 11.0/20 · P/BV 1.65× · P/BV÷ROE 0.14 · 70% evidence Relative strength 19.4/20 · Lead over its industry 11.4% · Lead over S&P 500 11.1% · 1 year 40.4% · 100% evidence · 7 of 12 weeks ahead Exact sum: 22.4 + 8.5 + 11 + 19.4 = 61.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [HSBC Holdings plc](https://www.sectoralpha.in/us/stocks/hsbc) HSBC · quiet · Evidence leans up · 80% evidence 59.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.9/35 · Income 16.4% · Profit 59.4% · 81% evidence Capital efficiency 14.1/25 · ROA 0.9% · ROE 16.1% · GNPA n/a · 68% evidence Valuation 13.0/20 · P/BV 1.73× · P/BV÷ROE 0.11 · 70% evidence Relative strength 2.0/20 · Lead over its industry -9.8% · Lead over S&P 500 -10.1% · 1 year 18.5% · 100% evidence · 5 of 12 weeks ahead Exact sum: 29.9 + 14.1 + 13 + 2 = 59 · What this means: Earnings are strong; relative strength in its sector is -9.8% and the one-year return is 18.5%. 6. [Royal Bank of Canada](https://www.sectoralpha.in/us/stocks/ry) RY · quiet · Evidence leans up · 80% evidence 55.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.7/35 · Income 11.4% · Profit 18.6% · 81% evidence Capital efficiency 14.2/25 · ROA 0.9% · ROE 15.7% · GNPA n/a · 68% evidence Valuation 6.9/20 · P/BV 2.81× · P/BV÷ROE 0.18 · 70% evidence Relative strength 16.1/20 · Lead over its industry 5.8% · Lead over S&P 500 5.5% · 1 year 40% · 100% evidence · 2 of 12 weeks ahead Exact sum: 18.7 + 14.2 + 6.9 + 16.1 = 55.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [UBS Group AG](https://www.sectoralpha.in/us/stocks/ubs) UBS · quiet · Evidence leans up · 76% evidence 55.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Income 10.7% · Profit 51.5% · 71% evidence Capital efficiency 9.2/25 · ROA 0.7% · ROE 13.4% · GNPA n/a · 68% evidence Valuation 11.7/20 · P/BV 1.72× · P/BV÷ROE 0.13 · 70% evidence Relative strength 9.9/20 · Lead over its industry -0.6% · Lead over S&P 500 -0.9% · 1 year 25.3% · 100% evidence · 4 of 12 weeks ahead Exact sum: 24.8 + 9.2 + 11.7 + 9.9 = 55.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Citigroup Inc.](https://www.sectoralpha.in/us/stocks/c) C · quiet · Evidence leans up · 80% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Income 11.1% · Profit 32.9% · 81% evidence Capital efficiency 9.3/25 · ROA 0.8% · ROE 11.3% · GNPA n/a · 68% evidence Valuation 16.1/20 · P/BV 1.03× · P/BV÷ROE 0.09 · 70% evidence Relative strength 6.3/20 · Lead over its industry -4.9% · Lead over S&P 500 -5.1% · 1 year 21.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 23.8 + 9.3 + 16.1 + 6.3 = 55.5 · What this means: Earnings are strong; relative strength in its sector is -4.9% and the one-year return is 21.7%. 9. [The Bank of N.T. Butterfield & Son Limited](https://www.sectoralpha.in/us/stocks/ntb) NTB · quiet · Evidence leans up · 76% evidence 54.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.8/35 · Income 5.9% · Profit 6.8% · 71% evidence Capital efficiency 20.4/25 · ROA 1.8% · ROE 22% · GNPA n/a · 68% evidence Valuation 14.1/20 · P/BV 2.04× · P/BV÷ROE 0.09 · 70% evidence Relative strength 5.0/20 · Lead over its industry -4.9% · Lead over S&P 500 -5.1% · 1 year 20.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 14.8 + 20.4 + 14.1 + 5 = 54.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 10. [Wells Fargo & Company](https://www.sectoralpha.in/us/stocks/wfc) WFC · turning · Evidence leans up · 80% evidence 54.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.4/35 · Income 5.1% · Profit 10% · 81% evidence Capital efficiency 15.3/25 · ROA 1.2% · ROE 14.7% · GNPA n/a · 68% evidence Valuation 15.1/20 · P/BV 1.36× · P/BV÷ROE 0.09 · 70% evidence Relative strength 10.2/20 · Lead over its industry -4.2% · Lead over S&P 500 -4.1% · 1 year -0.6% · 100% evidence · 3 of 12 weeks ahead Exact sum: 13.4 + 15.3 + 15.1 + 10.2 = 54 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 11. [Bank of Montreal](https://www.sectoralpha.in/us/stocks/bmo) BMO · quiet · Evidence leans up · 80% evidence 52.2 out of 100 Growth Capital Valuation Relative
12. [ING Groep N.V.](https://www.sectoralpha.in/us/stocks/ing) ING · quiet · Evidence leans down · 76% evidence 48.5 out of 100 Growth Capital Valuation Relative
13. [Banco Bilbao Vizcaya Argentaria, S.A.](https://www.sectoralpha.in/us/stocks/bbva) BBVA · quiet · Evidence leans down · 76% evidence 48.1 out of 100 Growth Capital Valuation Relative
14. Barclays PLC this page BCS · basing · Evidence leans down · 80% evidence 43.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.2/35 · Income 9.4% · Profit 18.3% · 81% evidence Capital efficiency 8.0/25 · ROA 0.6% · ROE 12.9% · GNPA n/a · 68% evidence Valuation 17.0/20 · P/BV 0.79× · P/BV÷ROE 0.06 · 70% evidence Relative strength 1.6/20 · Lead over its industry -13% · Lead over S&P 500 -13.2% · 1 year 3% · 100% evidence · 3 of 12 weeks ahead Exact sum: 17.2 + 8 + 17 + 1.6 = 43.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 15. [Bank of America Corporation](https://www.sectoralpha.in/us/stocks/bac) BAC · quiet · Evidence leans down · 80% evidence 43.8 out of 100 Growth Capital Valuation Relative
16. [The Toronto-Dominion Bank](https://www.sectoralpha.in/us/stocks/td) TD · turning · Evidence leans down · 80% evidence 42.6 out of 100 Growth Capital Valuation Relative
17. [Banco Santander, S.A.](https://www.sectoralpha.in/us/stocks/san) SAN · quiet · Evidence leans down · 76% evidence 39.7 out of 100 Growth Capital Valuation Relative
18. Forbright, Inc. FRBT · turning · Too little evidence to rank firmly · 33% evidence 43.8 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Banks - Diversified](https://www.sectoralpha.in/us/sectors/banks-diversified), all 18 compared on one page. ## Which companies are close to Barclays in size? Barclays is the 18th largest of 19 Banks - Diversified companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Bank of Montreal, The Bank of Nova Scotia, Canadian Imperial Bank of Commerce, The Bank of New York Mellon Corporation and ING Groep N.V. Just below it: The Bank of N.T. Butterfield & Son. ### Banks - Diversified companies close in size

1. [Bank of Montreal](https://www.sectoralpha.in/us/stocks/bmo) $119.4 billion
2. [The Bank of Nova Scotia](https://www.sectoralpha.in/us/stocks/bns) $114.1 billion
3. [Canadian Imperial Bank of Commerce](https://www.sectoralpha.in/us/stocks/cm) $106 billion
4. [The Bank of New York Mellon Corporation](https://www.sectoralpha.in/us/stocks/bny) $100.5 billion
5. [ING Groep N.V.](https://www.sectoralpha.in/us/stocks/ing) $88.1 billion
6. Barclays PLC $74.2 billion
7. [The Bank of N.T. Butterfield & Son Limited](https://www.sectoralpha.in/us/stocks/ntb) $2.2 billion

[All 19 Banks - Diversified companies, largest first](https://www.sectoralpha.in/us/sectors/banks-diversified#all-companies)

### Companies close in size in other industries

1. [Colgate-Palmolive Company](https://www.sectoralpha.in/us/stocks/cl) $77.4 billion · Household & Personal Products
2. [SLB N.V.](https://www.sectoralpha.in/us/stocks/slb) $77.2 billion · Oil & Gas Equipment & Services
3. Barclays PLC $76.7 billion
4. [AppLovin Corporation](https://www.sectoralpha.in/us/stocks/app) $76.6 billion · Advertising Agencies
5. [Canadian National Railway Company](https://www.sectoralpha.in/us/stocks/cni) $76.1 billion · Railroads

## What else do people ask about Barclays? ### What were Barclays's latest quarterly results? Barclays PLC reported total income of GBP 6.9 B and net profit of GBP 1.6 B for the Sep 2026 quarter. Income rose 4.9% and profit rose 13.0% compared with a year earlier. The net margin was 23.8%, 1.7 percentage points higher than a year earlier (as of 3 November 2026). ### What is Barclays's market cap? Barclays PLC's market capitalisation is $74.2 B at a stock price of $22.40. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Barclays performing? Barclays PLC's share price has been moving sideways for 8 weeks. In its latest quarter, income rose 4.9% and profit rose 13.0% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 8 weeks running (as of 3 November 2026). ### Will Barclays's stock price go up? This page does not forecast Barclays PLC's stock price. What it shows instead: the stock price is $22.40, and it has been moving sideways for 8 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Barclays in its business cycle? Barclays PLC's FY25 net margin was 23.0%, against a 5-year range of 18.2% to 27.5%: the middle of its own range, neither a peak nor a low. The latest quarter was 23.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Barclays story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Barclays a stock worth studying right now? What the numbers show: Barclays PLC's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.